Literature DB >> 24755782

Transforming high risk to high yield.

Karsten Bartels1, Almut Grenz, Holger K Eltzschig.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24755782      PMCID： PMC4043957          DOI： 10.1097/ALN.0000000000000217

Source DB:  PubMed          Journal:  Anesthesiology        ISSN： 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  12 in total

1.  Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study.

Authors:  Ognjen Gajic; Ousama Dabbagh; Pauline K Park; Adebola Adesanya; Steven Y Chang; Peter Hou; Harry Anderson; J Jason Hoth; Mark E Mikkelsen; Nina T Gentile; Michelle N Gong; Daniel Talmor; Ednan Bajwa; Timothy R Watkins; Emir Festic; Murat Yilmaz; Remzi Iscimen; David A Kaufman; Annette M Esper; Ruxana Sadikot; Ivor Douglas; Jonathan Sevransky; Michael Malinchoc
Journal:  Am J Respir Crit Care Med       Date:  2010-08-27       Impact factor: 21.405

2.  Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung.

Authors:  Jae W Lee; Xiaohui Fang; Naveen Gupta; Vladimir Serikov; Michael A Matthay
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-31       Impact factor: 11.205

3.  Derivation and diagnostic accuracy of the surgical lung injury prediction model.

Authors:  Daryl J Kor; David O Warner; Anas Alsara; Evans R Fernández-Pérez; Michael Malinchoc; Rahul Kashyap; Guangxi Li; Ognjen Gajic
Journal:  Anesthesiology       Date:  2011-07       Impact factor: 7.892

4.  Predicting risk of postoperative lung injury in high-risk surgical patients: a multicenter cohort study.

Authors:  Daryl J Kor; Ravi K Lingineni; Ognjen Gajic; Pauline K Park; James M Blum; Peter C Hou; J Jason Hoth; Harry L Anderson; Ednan K Bajwa; Raquel R Bartz; Adebola Adesanya; Emir Festic; Michelle N Gong; Rickey E Carter; Daniel S Talmor
Journal:  Anesthesiology       Date:  2014-05       Impact factor: 7.892

Review 5.  Respiratory intensive care.

Authors:  H Pontoppidan; R S Wilson; M A Rie; R C Schneider
Journal:  Anesthesiology       Date:  1977-08       Impact factor: 7.892

6.  Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial.

Authors:  Giles J Peek; Miranda Mugford; Ravindranath Tiruvoipati; Andrew Wilson; Elizabeth Allen; Mariamma M Thalanany; Clare L Hibbert; Ann Truesdale; Felicity Clemens; Nicola Cooper; Richard K Firmin; Diana Elbourne
Journal:  Lancet       Date:  2009-09-15       Impact factor: 79.321

7.  Crosstalk between the equilibrative nucleoside transporter ENT2 and alveolar Adora2b adenosine receptors dampens acute lung injury.

Authors:  Tobias Eckle; Kelly Hughes; Heidi Ehrentraut; Kelley S Brodsky; Peter Rosenberger; Doo-Sup Choi; Katya Ravid; Tingting Weng; Yang Xia; Michael R Blackburn; Holger K Eltzschig
Journal:  FASEB J       Date:  2013-04-19       Impact factor: 5.191

8.  Recent trends in acute lung injury mortality: 1996-2005.

Authors:  Sara E Erickson; Greg S Martin; J Lucian Davis; Michael A Matthay; Mark D Eisner
Journal:  Crit Care Med       Date:  2009-05       Impact factor: 7.598

Review 9.  Has mortality from acute respiratory distress syndrome decreased over time?: A systematic review.

Authors:  Jason Phua; Joan R Badia; Neill K J Adhikari; Jan O Friedrich; Robert A Fowler; Jeff M Singh; Damon C Scales; David R Stather; Amanda Li; Andrew Jones; David J Gattas; David Hallett; George Tomlinson; Thomas E Stewart; Niall D Ferguson
Journal:  Am J Respir Crit Care Med       Date:  2008-11-14       Impact factor: 21.405

10.  Adora2b adenosine receptor engagement enhances regulatory T cell abundance during endotoxin-induced pulmonary inflammation.

Authors:  Heidi Ehrentraut; Joseph A Westrich; Holger K Eltzschig; Eric T Clambey
Journal:  PLoS One       Date:  2012-02-28       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.